Use Of Riboflavin In The Treatment Of Hypertension

Abstract

The invention provides the use of riboflavin in the manufacture of a medicament for the treatment or prophylaxis of elevated blood pressure in a subject homozygous or heterozygous for the MTHFR C677T polymorphism. The invention also provides a pharmaceutical product for the treatment or prophylaxis of elevated blood pressure in a subject homozygous or heterozygous for the MTHFR C677T polymorphism, comprising a pharmaceutically effective amount of an anti-hypertensive agent and riboflavin, and the invention further provides a method of treatment of such a subject comprising the administration of riboflavin.


Claims
Download PDF
Document Preview
Document History
  • Publication: Aug 28, 2008
  • Application: Feb 22, 2008
    WO EP 2008001437 W
  • Priority: Feb 23, 2007
    GB GB 0703514 A

Download Citation


Sign in to the Lens

Feedback